Breaking News! MoMed Biotech Wins First Prize in the Growth Enterprise Category at the 2025

T&K（Guangdong Taienkang Pharmaceutical Co., Ltd.‌） Visits MoMed Biotech, Jointly Exploring New Possibilities for Pharmaceutical Innovation Cooperation

Breaking News | MoMed Biotech Discovers Novel Scaffold GCGR Biased Small-Molecule Inhibitor

CCTV Dong Qian Exclusive Interview | Bai Chen: Technology Charts a New Direction for AI-Driven New Drug Development

Good News | MoMed Biotech Makes Zhejiang